Transgenomic to Acquire Clinical Data's Genetic Test Business for $15.4M

The assets being acquired include 11 Familion tests as well as contracts with private and government health insurers for test reimbursement through policies offering access to genetic testing for an estimated 280 million patients.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.